great eagle health holdings was successfully listed on the main board of australia, becoming the first chinese eco-最新凯时注册

great eagle health holdings was successfully listed on the main board of australia, becoming the first chinese eco-pharmaceutical company to be listed in australia

(the picture shows on july 3, 2017, great eagle health holdings, chairman of the board of directors, mr. zhang mingwang, and executive director, ms. chen linxiang, sounded the first bell for listing on the asx in sydney.) 

(the picture shows on july 3, 2017, great eagle health holdings was successfully listed on the australian stock exchange.)

on july 3, at 12 noon, sydney time, great eagle health holdings (stock code ehh) australian main board (asx) listing bell was held in sydney, australia. it became my country’s first chinese eco-pharmaceutical company listed on the australian main board. the health product brand made a gorgeous appearance in the international market. the great eagle australia main board listing was guided and sponsored by idc capital throughout the process, and was enthusiastically welcomed by australian and international investors. it created the largest financing amount for the listing of “china concept stocks” on the asx in the first half of 2017.

the main leader of the australian securities exchange, the commercial consul of the chinese embassy in australia, the president of xinhua news agency in canberra, australia, the former deputy foreign minister of australia, the former minister of sports and tourism, the chairman of the australian zhejiang chamber of commerce, the chairman of the australian wenzhou chamber of commerce, idc more than 100 guests, including partners of the capital, and more than 10 journalists from chinese and foreign media attended and witnessed this historical moment.

at the bell ringing ceremony, zhang mingwang, chairman of the board of directors of great eagle health holdings, spoke on behalf of the board of directors: "the official listing of great eagle health holdings co., ltd. on the australian stock exchange is an important milestone in the history of great eagle development. listing is not the end, but rather the new starting point is also the beginning of eagle's internationalization and publicization. the successful listing reflects that eagle's business model, growth potential, profitability, management team, development prospects, etc. are widely recognized by the capital market."

zhang mingwang said that with the improvement of chinese consumption level, health awareness and favorable policies, china's health industry has ushered in a golden age in recent years. as a leading company in the health care product industry in fujian province, great eagle has the responsibility and ability to connect australia’s only health care product produced in accordance with pharmaceutical standards with china’s largest health care market in the world, and we are also confident to use the iron sheets developed and manufactured by great eagle. dendrobium and other precious chinese herbal medicine health products are shared with australian citizens.

he said that we chose the australian main board to list in order to build a bridge between china and australia, to achieve the complementarity of resources and the market, and to make use of australia's mature scientific research, products and capital market. at present, great eagle has carried out industry-university-research cooperation with monash university, a prestigious australian university, and has obtained the exclusive agent rights of australia's xerion company to treat onychomycosis skin diseases in china. it will also launch a patented food for reducing diabetes mellitus. great eagle also attracted a long-term investment of 11 million australian dollars (approximately 60 million rmb) from nativa, the largest health care company in south africa. great eagle products will open up the sales market in africa. we will also use this bridge to promote chinese medicine products to the world, and let chinese medicine science and technology culture benefit the world.

yingjun pharmaceutical is a comprehensive eco-pharmaceutical enterprise with a 16-year history of development, focusing on the research and development, production and sales of medical and health products, nutritional products and dietary supplements. it is a national intellectual property advantage enterprise (with 23 independent knowledge property rights), high-tech enterprises in xiamen, famous trademarks in fujian province, and the top ten golden signs of the xiamen economy in 2016, are in the forefront of the modernization of traditional chinese medicine represented by "ancient tree epiphysis" dendrobium officinale.

eagle king will seize the favorable momentum of the development of china's big health industry, rely on australia's r&d technology advantages in the health industry, leverage on the international capital market, achieve rapid development, and return shareholders with the best performance. 

(the picture shows the leader of the asx and mr. mingwang zhang, president of great eagle health holdings) 

(the picture shows the australian asx listing bell ringing ceremony, yingjun health holdings president mr. zhang mingwang (first from right), idc capital management partner jiang ting (second from right) answering questions from chinese and foreign media reporters)